Inhibition of proprotein convertase 5/6 activity: potential for nonhormonal women-centered contraception

被引:3
|
作者
Aljofan, Mohamad [1 ]
Singh, Harmeet [1 ]
Ho, Huiting [1 ,2 ]
Xie, Shuwu [3 ]
Zhu, Yan [3 ]
Sun, Zhaogui [3 ]
Guo, Xiangjie [3 ]
Wang, Jian [2 ]
Nie, Guiying [1 ]
机构
[1] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[2] Monash Univ, Clayton, Vic 3169, Australia
[3] Shanghai Inst Planned Parenthood Res, NPFPC Key Lab Contracept & Devices, Shanghai 200032, Peoples R China
基金
英国医学研究理事会; 比尔及梅琳达.盖茨基金会;
关键词
Proprotein convertase 5/6; Female contraception; Embryo implantation; Decidualization; Vaginal delivery; EMBRYO IMPLANTATION; ACTIVATION; PC6; IDENTIFICATION; EXPRESSION; GP160; DECIDUALIZATION; PROGESTERONE; DELIVERY; UTERUS;
D O I
10.1016/j.contraception.2011.10.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Proprotein convertase 5/6 (PC6) is critical for endometrial epithelial receptivity and stromal cell decidualization for embryo implantation in women. We hypothesized that inhibiting PC6 could block implantation for contraception. The aim of this study was to prove this concept using human cell models and rabbits. Study Design: A potential PC6 inhibitor, C1239-PEG-Poly R, was biochemically confirmed to be a potent PC6 inhibitor. The potential contraceptive action of the inhibitor was then tested in decidualization of primary human endometrial stromal cells in a human trophoblast spheroid attachment model and in vivo in rabbits. Results: The PC6 inhibitor C1239-PEG-Poly R inhibited in a dose-dependent manner both decidualization and spheroid attachment. Vaginal delivery of 200 mu L of the inhibitor at a final concentration of 5 mM to rabbits over a 3-day period starting 6 days after mating resulted in a 60% decrease in implantation and, hence, pregnancy. Conclusions: This study presents proof of concept that PC6 inhibition has the potential to block embryo implantation, providing nonhormonal contraception for women. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:602 / 610
页数:9
相关论文
共 50 条
  • [31] Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
    Artin, Joy
    Elsabagh, Yumn A.
    Rashed, Laila
    Hussein, Mohamed A.
    ARCHIVES OF RHEUMATOLOGY, 2023, 38 (02) : 249 - 256
  • [32] The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A-Functional consequences of natural mutations and post-translational modifications
    Benjannet, Suzanne
    Rhainds, David
    Hamelin, Josee
    Nassoury, Nasha
    Seidah, Nabil G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (41) : 30561 - 30572
  • [33] Reduction of lipoprotein(a) with proprotein convertase subtilisin/kexin type 9 inhibitor as a potential contributor to modulating coronary inflammatory activity: insights from serial pericoronary adipose tissue analysis
    Kitahara, Satoshi
    Kataoka, Yu
    Miura, Hiroyuki
    Noguchi, Teruo
    EUROPEAN HEART JOURNAL, 2022, 43 (16) : 1597 - 1597
  • [34] Carotid Plaque Lipid Content is Reduced After 6 Months of Proprotein Convertase Subtilisin Kexin Type 9 Inhibition With Alirocumab: an Interim Analysis of a Serial Magnetic Resonance Imaging Study
    Sun, Jie
    Lepor, Norman E.
    Canton, Gador
    Contreras, Laurn
    Hippe, Daniel S.
    Isquith, Daniel
    Balu, Niranjan
    Kedan, Ilan
    Simonini, Americo
    Yuan, Chun
    Zhao, Xue-Qiao
    Hatsukami, Thomas S.
    CIRCULATION, 2019, 140
  • [35] Functional Characterization of Alternative and Classical Pathway C3/C5 Convertase Activity and Inhibition Using Purified Models
    Zwarthoff, Seline A.
    Berends, Evelien T. M.
    Mol, Sanne
    Ruyken, Maartje
    Aerts, Piet C.
    Jozsi, Mihaly
    de Haas, Carla J. C.
    Rooijakkers, Suzan H. M.
    Gorham, Ronald D., Jr.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [36] Inhibition and transcriptional silencing of a subtilisin-like proprotein convertase, PACE4/SPC4, reduces the branching morphogenesis of and AQP5 expression in rat embryonic submandibular gland
    Akamatsu, Tetsuya
    Azlina, Ahmad
    Purwanti, Nunuk
    Karabasil, Mileva Ratko
    Hasegawa, Takahiro
    Yao, Chenjuan
    Hosoi, Kazuo
    DEVELOPMENTAL BIOLOGY, 2009, 325 (02) : 434 - 443
  • [37] First Syntheses of Lorneic Acids A and B with Potential PDE5 Inhibition Activity
    Ma, Xiang
    Song, Yuting
    Liu, Hao
    Chen, Ruijiao
    Chen, Xiaochuan
    SYNLETT, 2012, (04) : 607 - 610
  • [38] Relationship of 5-HT1A and 5-HT2A activity to behavioral inhibition in healthy women
    Bailer, UF
    Kaye, WH
    Frank, GK
    Henry, SE
    Price, JC
    Meltzer, CC
    Weissfeld, LA
    Wagner, A
    McConaha, CW
    Mathis, CA
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S83 - S83
  • [39] Proprotein convertase PC5 regulation by PDGF-BB involves PI3-kinase/p70s6-kinase activation in vascular smooth muscle cells
    Stawowy, P
    Blaschke, F
    Kilimnik, A
    Goetze, S
    Kallisch, H
    Chrétien, M
    Marcinkiewicz, M
    Fleck, E
    Graf, K
    HYPERTENSION, 2002, 39 (02) : 399 - 404
  • [40] THE LOW C5 CONVERTASE ACTIVITY OF THE C4A6 ALLOTYPE OF HUMAN-COMPLEMENT COMPONENT C-4
    KINOSHITA, T
    DODDS, AW
    LAW, SKA
    INOUE, K
    BIOCHEMICAL JOURNAL, 1989, 261 (03) : 743 - 748